发明名称 PODXL-protein i endetarms- og tyktarmskræft
摘要 <p>The present disclosure provides a method for determining whether a mammalian subject having a colorectal cancer belongs to a first or a second group, wherein the prognosis of subjects of the first group is better than the prognosis of subjects of the second group, comprising the steps of: a) evaluating an amount of PODXL protein in at least part of a sample earlier obtained from the subject, and determining a sample value corresponding to the evaluated amount; b) comparing said sample value from step a) with a predetermined reference value; and if said sample value is higher than said reference value, c1) concluding that the subject belongs to said second group; and if said sample value is lower than or equal to said reference value, c2) concluding that the subject belongs to said first group. Related uses, means and a method of treatment are also provided.</p>
申请公布号 DK2494359(T3) 申请公布日期 2015.02.16
申请号 DK20100768960T 申请日期 2010.10.26
申请人 ATLAS ANTIBODIES AB 发明人 JIRSTRÖM, KARIN;UHLÉN, MATHIAS;PONTÉN, FREDRIK
分类号 G01N33/574;C07K16/30 主分类号 G01N33/574
代理机构 代理人
主权项
地址